Israeli company BrainStorm Cell Therapeutics Inc. announced that it was awarded a NIS3 million (approx. $795,000) grant from Israel’s Office of the Chief Scientist (OCS) for the year 2013. The grant is intended to support BrainStorm’s Research and Development program for its innovative stem cell therapy candidate NurOwn.
Related posts
Accelerator For Israeli Startups Raises $20 million
June 01, 2023
Facebook comments